Synopsis of recent research by authors named "Jianjian Yang"
- Jianjian Yang's recent research encompasses a diverse range of topics, prominently focusing on cardiovascular health, specifically the development of ROS-responsive nanomicelles for targeted delivery of celastrol to treat cardiac hypertrophy, highlighting its potential in regulating the NF-κB signaling pathway.
- Yang's investigations into stroke prevention reveal mixed results regarding the efficacy of folic acid, as evidenced by his systematic review and meta-analysis of observational studies and randomized controlled trials, indicating a need for further research to clarify its role in stroke prevention strategies.
- The research also delves into cancer immunotherapy, particularly the examination of Death Associated Protein Kinase 1 (DAPK1) as a prognostic marker and its association with immune responses in various cancers, suggesting that understanding such markers may improve therapeutic approaches involving immunotherapy.
